‘It’s a game changer’: Local scientist’s cancer research working to find easier way to save lives
A local scientist is using artificial intelligence to find new uses for existing drugs to hopefully save both lives and money ...
Becker's Hospital Review5h
Dana-Farber names pediatric oncology leader
Kimberly Stegmaier, MD, has been named chair of pediatric oncology at Boston-based Dana-Farber Cancer Institute. She has also been appointed associate chief in the division of hematology/oncology at ...
3 Madison Residents To Run Boston Marathon For Charity
On April 21, three Madison, Connecticut residents are running to defy cancer as a member of the Dana-Farber Marathon ...
Cancer vaccine shows promising results for certain patients
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.
EurekAlert!10d
Dana-Farber researchers present findings at 2025 ASCO Genitourinary Cancers Symposium
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
Harvard Medical School15d
Kidney Cancer Vaccine Shows Promise in Early Trial
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
Armed robbery in Revesby1d
Stegmaier Appointed Pediatric Oncology Chair at Dana-Farber
She will also serve as Associate Chief of the Division of Hematology/Oncology at Boston Children's HospitalKimberly Stegmaier ...
Noozhawk1d
Santa Barbara’s Brianna Hammond Running Boston Marathon for Dan-Farber Challenge
Brianna Hammond of Santa Barbara, California is running to defy cancer as a member of the Dana-Farber Marathon ...
Arcus Biosciences presents new data for casdatifan
Arcus Biosciences (RCUS) presented new data for casdatifan, a HIF-2a inhibitor with best-in-class potential, in an oral plenary session by Dr.
Arcus says new data demonstrated ‘best-in-class potential’ for casdatifan
Arcus Biosciences (RCUS) presented new data for casdatifan, a HIF-2a inhibitor with best-in-class potential, in an oral plenary session by Dr.
EurekAlert!2d
Kimberly Stegmaier named as Pediatric Oncology Chair at Dana-Farber
Kimberly Stegmaier, MD, was named Chair of Pediatric Oncology at Dana-Farber Cancer Institute and Associate Chief of the Division of Hematology/Oncology at Boston Children’s Hospital, in an ...